array(3) { ["company_details"]=> array(13) { ["name"]=> string(26) "Bio-RAD Laboratories, Inc." ["slug"]=> string(33) "001cd-us-bio-rad-laboratories-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/9d1c28c2-1b47-4093-8ed2-5151f3fe7920" ["description"]=> string(867) "Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, advancing science and saving lives, together. #Biotechnology #Biotech #STEM #Research #Biology #Chemistry #Science #PeerReviewed #Diabetes #CancerResearch #HIVResearch #Laboratory #BioRad #Cancer #DiabetesResearch #AIDSResearch #ClinicalDiagnostics" ["address_street"]=> string(20) "1000 Alfred Nobel Dr" ["address_place"]=> string(8) "Hercules" ["address_region"]=> string(10) "California" ["founding_date"]=> string(10) "1952-02-08" ["website_domain"]=> string(11) "bio-rad.com" ["website_url"]=> string(23) "https://www.bio-rad.com" ["industry_codes"]=> array(3) { [0]=> string(42) "In Vitro and In Vivo Diagnostic Substances" [1]=> string(33) "Laboratory Analytical Instruments" [2]=> string(47) "Electromedical and Electrotherapeutic Apparatus" } ["employee_count"]=> int(7900) ["article_count"]=> int(658) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(87) "Acute Intermittent Porphyria Market Changes in 2024: Strategies for Survival and Growth" ["snippet_en"]=> string(87) "Acute Intermittent Porphyria Market Changes in 2024: Strategies for Survival and Growth" ["url"]=> string(145) "https://industrytoday.co.uk/market-research-industry-today/acute-intermittent-porphyria-market-changes-in-2024-strategies-for-survival-and-growth" ["image_url"]=> NULL ["source"]=> string(19) "industrytoday.co.uk" ["publication_date"]=> string(10) "2024-04-15" ["categories"]=> array(1) { [0]=> string(15) "Market Movement" } } [1]=> array(7) { ["title_en"]=> string(56) "OncoCyte reports Q4 revenue $314,000, consensus $320,000" ["snippet_en"]=> string(169) "Loss from operations for the three months ended December 31, 2023, was $16.2M, an increase of 39% compared to fourth quarter 2022. “In 2023, we made significant pro..." ["url"]=> string(89) "https://www.tipranks.com/news/the-fly/oncocyte-reports-q4-revenue-314000-consensus-320000" ["image_url"]=> NULL ["source"]=> string(12) "tipranks.com" ["publication_date"]=> string(10) "2024-04-12" ["categories"]=> array(1) { [0]=> string(24) "Quarterly/Annual Figures" } } [2]=> array(7) { ["title_en"]=> string(148) "Bio-Rad and Allegheny Health Network Cancer Institute collaborate to advance personalized monitoring of solid tumor cancers with droplet digital PCR" ["snippet_en"]=> string(188) "Collaboration aims to grow clinical evidence supporting the use of bio-Rad’s ddPCRTM technology for molecular residual disease monitoring of patients across a range of solid tumor types." ["url"]=> string(147) "https://www.technologynetworks.com/tn/product-news/bio-rad-and-allegheny-health-network-cancer-institute-collaborate-to-advance-personalized-385608" ["image_url"]=> NULL ["source"]=> string(22) "technologynetworks.com" ["publication_date"]=> string(10) "2024-04-11" ["categories"]=> array(1) { [0]=> string(13) "Collaboration" } } [3]=> array(7) { ["title_en"]=> string(97) "Hartford Investment Management Co. Has $452,000 Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)" ["snippet_en"]=> string(249) "Hartford Investment Management Co. lowered its position in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 2.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC)." ["url"]=> string(134) "https://www.defenseworld.net/2024/04/08/hartford-investment-management-co-has-452000-position-in-bio-rad-laboratories-inc-nysebio.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/90fd6be9-d94a-403b-9ecd-b42236ac8bbd" ["source"]=> string(16) "defenseworld.net" ["publication_date"]=> string(10) "2024-04-08" ["categories"]=> array(4) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(18) "General Investment" [2]=> string(9) "Valuation" [3]=> string(11) "Regulations" } } [4]=> array(7) { ["title_en"]=> string(169) "Pasteurella multocida activates apoptosis via the FAK-AKT-FOXO1 axis to cause pulmonary integrity loss, bacteremia, and eventually a cytokine storm - Veterinary Research" ["snippet_en"]=> string(299) "Pasteurella multocida is an important zoonotic respiratory pathogen capable of infecting a diverse range of hosts, including humans, farm animals, and wild animals. However, the precise mechanisms by which P. multocida compromises the pulmonary integrity of mammals and subsequently induces systemic" ["url"]=> string(80) "https://veterinaryresearch.biomedcentral.com/articles/10.1186/s13567-024-01298-7" ["image_url"]=> string(78) "https://images.businessradar.com/articles/1204340f-8042-48a9-8032-93bee69a90a4" ["source"]=> string(17) "biomedcentral.com" ["publication_date"]=> string(10) "2024-04-08" ["categories"]=> array(0) { } } [5]=> array(7) { ["title_en"]=> string(144) "A porcine kidney-derived clonal cell line with clear genetic annotation is highly susceptible to African swine fever virus - Veterinary Research" ["snippet_en"]=> string(296) "African Swine Fever virus (ASFV), the causative agent of African swine fever, is a highly lethal hemorrhagic virus affecting domestic pigs and wild boars. The primary target cells for ASFV infection are porcine alveolar macrophages( PAMs), which are difficult to obtain and maintain in vitro, and" ["url"]=> string(80) "https://veterinaryresearch.biomedcentral.com/articles/10.1186/s13567-024-01300-2" ["image_url"]=> string(78) "https://images.businessradar.com/articles/827cd5f5-7790-441e-849a-be6cdd72a228" ["source"]=> string(17) "biomedcentral.com" ["publication_date"]=> string(10) "2024-04-04" ["categories"]=> array(0) { } } [6]=> array(7) { ["title_en"]=> string(145) "Bio-Rad launches first Ultrasensitive Multiplexed Digital PCR Assay for breast cancer mutation detection in clinical research | Cambridge Network" ["snippet_en"]=> string(204) "Highly Sensitive and Multiplexed Assay for the Detection, Discrimination, and Quantification of Key Mutations in ESR1 Gene for Breast Cancer, Developed for Bio-Rad’s QX600TM Droplet DigitalTM PCR System" ["url"]=> string(130) "https://www.cambridgenetwork.co.uk/news/bio-rad-launches-first-ultrasensitive-multiplexed-digital-pcr-assay-breast-cancer-mutation" ["image_url"]=> NULL ["source"]=> string(22) "cambridgenetwork.co.uk" ["publication_date"]=> string(10) "2024-04-03" ["categories"]=> array(4) { [0]=> string(5) "R & D" [1]=> string(14) "Product Launch" [2]=> string(5) "Legal" [3]=> string(10) "New Market" } } [7]=> array(7) { ["title_en"]=> string(116) "Laboratory Equipment and Disposables Market Price Trends Analysis Agilent Technologies, Bio-Rad Laboratories, Bruker" ["snippet_en"]=> string(125) "Laboratory Equipment and Disposables Market Price Trends Analysis Agilent Technologies, Bio-Rad Laboratories, Bruker - Amoré" ["url"]=> string(139) "http://amore.ng/news/47/laboratory-equipment-and-disposables-market-price-trends-analysis-agilent-technologies-bio-rad-laboratories-bruker/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/eb91a7f5-4a64-45ab-95c4-11ba821d36f3" ["source"]=> string(8) "amore.ng" ["publication_date"]=> string(10) "2024-04-02" ["categories"]=> array(2) { [0]=> string(11) "Competition" [1]=> string(15) "Market Movement" } } [8]=> array(7) { ["title_en"]=> string(57) "New York: very difficult session for Bio-Rad Laboratories" ["snippet_en"]=> string(98) "Bio-Rad Laboratories falls significantly behind, exhibiting a negative percentage change of 7.54%." ["url"]=> string(117) "https://www.teleborsa.it/News/2024/04/18/new-york-seduta-molto-difficile-per-bio-rad-laboratories-223_TLB-1LINER.html" ["image_url"]=> NULL ["source"]=> string(12) "teleborsa.it" ["publication_date"]=> string(10) "2024-04-01" ["categories"]=> array(0) { } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(66) } [1]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(51) } [2]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(29) } [3]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(28) } [4]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(27) } [5]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(24) } [6]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(23) } [7]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(20) } [8]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(20) } [9]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(19) } [10]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(19) } [11]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(18) } [12]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(14) } [13]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(14) } [14]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(13) } [15]=> array(2) { ["name"]=> string(18) "Ecological Impacts" ["count"]=> int(12) } [16]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(9) } [17]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(9) } [18]=> array(2) { ["name"]=> string(11) "Regulations" ["count"]=> int(9) } [19]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(8) } [20]=> array(2) { ["name"]=> string(10) "New Market" ["count"]=> int(8) } [21]=> array(2) { ["name"]=> string(27) "Business Model & Innovation" ["count"]=> int(7) } [22]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(7) } [23]=> array(2) { ["name"]=> string(6) "Merger" ["count"]=> int(7) } [24]=> array(2) { ["name"]=> string(16) "Case Settlements" ["count"]=> int(6) } [25]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(6) } [26]=> array(2) { ["name"]=> string(13) "Credit Rating" ["count"]=> int(5) } [27]=> array(2) { ["name"]=> string(15) "Business Ethics" ["count"]=> int(5) } [28]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(5) } [29]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(5) } } } 001cd-us-bio-rad-laboratories-inc